| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $93.8M | +121.7% |
| SG&A Expense | $20.2M | +7.4% |
| Operating Income | -$114.0M | -86.5% |
| Income Tax | $0 | — |
| Net Income | -$102.3M | -95.4% |
| EPS (Basic) | -$1.71 | -58.3% |
| EPS (Diluted) | -$1.71 | -58.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.6M | -46.7% |
| Short-term Investments | $135.9M | -23.0% |
| Current Assets | $178.3M | -27.7% |
| Total Assets | $239.0M | -22.9% |
| Current Liabilities | $27.6M | +112.8% |
| Long-term Debt | $29.4M | -1.6% |
| Total Liabilities | $57.2M | +32.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$86.2M | -100.2% |
| Investing Cash Flow | $48.0M | +128.0% |
| Financing Cash Flow | $6.9M | -95.4% |
| Stockholders' Equity |
| $181.8M |
| -31.9% |